Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001648627-17-000001
Filing Date
2017-08-01
Accepted
2017-08-01 14:57:53
Documents
1
Effectiveness Date
2017-08-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10219
  Complete submission text file 0001648627-17-000001.txt   11240
Mailing Address 3210 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3210 MERRYFIELD ROW SAN DIEGO CA 92121 619-866-4589
Amplyx Pharmaceuticals, Inc. (Filer) CIK: 0001648627 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-291889 | Film No.: 17996360